Whalegun
Home

Travere Therapeutics TVTX paid The Health Equity Strategies Group $15.5K for lobbying in Q1 2024 · Health Issues, Medical and 2 more issues

Trade details

Type
Lobbying report
Amount
$15,500
Quarter
Q1 2024
Stock
Travere Therapeutics TVTX
Client
Travere Therapeutics
Reported
24/05/02

Down 31.1% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/01~24/04/30

Travere Therapeutics's other lobbying reports

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 08/04

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $70K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $140K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 05/19

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $80K

    Reported 04/20

Travere Therapeutics TVTX paid The Health Equity Strategies Group $15.5K for lobbying in Q1 2024 · Health Issues, Medical and 2 more issues | Whalegun